Difference between revisions of "Injection of Non-Prescription drugs"
| Line 20: | Line 20: | ||
UNACCEPTABLE if injected drugs of addiction within the previous five years | UNACCEPTABLE if injected drugs of addiction within the previous five years | ||
| − | If donor | + | UNACCEPTABLE if currently injecting androgenic steroid, or other non-addictive medications |
| + | |||
| + | If donor last injected androgenic steroid, or other non-addictive medications OVER 6 WEEKS AGO then they may proceed at the discretion of the requesting transplant centre. Inform TC and inform Donor Provision team. | ||
==Justification for guidance== | ==Justification for guidance== | ||
Revision as of 12:03, 3 November 2016
Contents
Condition
Injection of any drug or other substance not prescribed by a qualified physician or other healthcare professional. This encompasses, for example, drugs of addiction such as heroin, and use of non-prescribed injected anabolic steroids.
Individual at risk
Recipient
Guidance at RECRUITMENT
UNACCEPTABLE if injected drugs of addiction within the previous five years
UNACCEPTABLE if injected other non-prescription drugs, such as anabolic steroids, within the previous six months
Guidance at CT/WORK-UP
UNACCEPTABLE if injected drugs of addiction within the previous five years
UNACCEPTABLE if currently injecting androgenic steroid, or other non-addictive medications
If donor last injected androgenic steroid, or other non-addictive medications OVER 6 WEEKS AGO then they may proceed at the discretion of the requesting transplant centre. Inform TC and inform Donor Provision team.
Justification for guidance
Use of non-prescribed injected drugs of addiction is associated with a considerably higher risk of transmission of blood borne infectious diseases.
Although case reports of transmission of hepatitis C have been reported in users of androgenic steroids have been reported, the exposure risk remains very low and such donors may proceed at the discretion of the requesting transplant centre.
References
Elghouzzi MH, Bouchardeau F, Pillonel J, Boiret E, Tirtaine C, Barlet V et al. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 2000; 79(3): 138-44.
Aitken C, Delalande C, Stanton K. Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia. Drug Alcohol Depend 2002; 65(3): 303-8.
Midgley SJ, Heather N, Best D, Henderson D, McCarthy S, Davies JB. Risk behaviours for HIV and hepatitis infection among anabolic-androgenic steroid users. AIDS Care 2000; 12(2): 163-70.
Rich JD, Dickinson BP, Merriman NA, Flanigan TP. Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter. Am J Gastroenterol 1998; 93(9): 1598.
Version
Version 1. Edition 1
1 June 2016
